StonvexLoading…
StonvexStonvexStonvexCore line items from FCN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.79B | $3.70B | $3.49B | $3.03B |
Operating Income | $389.08M | $347.36M | $377.56M | $303.88M |
Net Income | $270.87M | $280.09M | $274.89M | $235.51M |
EPS (Diluted) | $8.24 | $7.81 | $7.71 | $6.58 |
Total Assets | $3.49B | $3.60B | $3.33B | $3.24B |
Total Liabilities | $1.76B | $1.34B | $1.34B | $1.56B |
Cash & Equivalents | $265.09M | $660.49M | $303.22M | $491.69M |
Free Cash Flow OCF − CapEx | $93.60M | $359.69M | $174.98M | $135.47M |
Shares Outstanding | 30.86M | 35.91M | 35.52M | 34.03M |